Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer
Cynthia, X. , Sánchez, César , Crowder, Robert J., Creekmore, Allison, Guo, Zhanfang , Doyle, Austin, Erlichman, Charles , Gao, Feng , Naughton, Michael J. , Pluard, Timothy , Hoog, Jeremy , Lockhart, A. Craig , Ellis, Matthew J. , Sánchez, César

Clinical Cancer Research | January 18, 2016 | Volume: 22 | Issue: 11 | Pages: 2650-2658

10.1158/1078-0432.ccr-15-2160 | PMID 26783290 Get It

Abstract Purpose: PI3K/AKT pathway activation is an important endocrine resistance mechanism in estrogen receptor–positive (ER+) breast cancer. After promising preclinical modeling of MK-2206, an allosteric pan-AKT inhibitor, with either estrogen deprivation or fulvestrant, we conducted a phase I trial in patients with metastatic ER+HER2− breast cancer to determine the recommended phase II treatment dose (RPTD) of MK-2206 when combined with either anastrozole, fulvestrant, or anastrozole/fulvestrant. Experimental Design: ER+ breast cancer cell lines were exposed in vitro to MK-2206 plus estrogen deprivation with or without fulvestrant and monitored for apoptosis. A standard 3+3 design was employed to first determine the maximum tolerated dose (MTD) of MK-2206 plus anastrozole based on cycle 1 toxicity. Each cycle was 28 days. The RPTD was determined on the basis of toxicities observed at MTD level during the first 3 cycles. Subsequent patients received MK-2206, at the RPTD determined above, plus fulvestrant or anastrozole/fulvestrant to define RPTD for these additional regimens. Results: MK-2206 induced apoptosis in parental ER+ but not in long-term estrogen-deprived cell lines, for which fulvestrant was required for apoptosis induction. Thirty-one patients enrolled. The RPTD was defined as MK-2206 150 mg orally weekly with prednisone prophylaxis for each combination. Grade 3 rash was dose limiting. 42% (95% CI, 23%–63%) patients derived clinical benefit without progression within 6 months. Response was not associated with tumor PIK3CA mutation. Conclusions: MK-2206 plus endocrine treatments were tolerable. MK-2206 in combination with anastrozole is being further evaluated in a phase II neoadjuvant trial for newly diagnosed ER+HER2− breast cancer. Clin Cancer Res; 22(11); 2650–8. ©2016 AACR. See related commentary by Jansen et al., p. 2599
Opinion and Special Articles: “Physician debtor”
Jones, Lyell K. , Scharf, Eugene L, Scharf, Eugene , Jones, Lyell K

Neurology | January 18, 2016 | Volume: 86 | Issue: 3 | Pages: No page available

10.1212/wnl.0000000000002299 | PMID 26783273 Get It

What can unmanned aerial systems offer healthcare?
Aho, Johnathon M. , Thiels, Cornelius A.

Journal of Unmanned Vehicle Systems | January 18, 2016 | Volume: 4 | Issue: 1 | Pages: 1-3

10.1139/juvs-2015-0033 Get It

In vivo, high‐frequency three‐dimensional cardiac MR elastography: Feasibility in normal volunteers
Arani, Arvin , Glaser, Kevin, Arunachalam, Shivaram P. , Rossman, Phillip J. , Lake, David S. , Trzasko, Joshua D. , McGee, Kiaran P. , Araoz, Philip A. , Glaser, Kevin L, Glaser, Kevin J. , Manduca, Armando , Ehman, Richard L. , Arunachalam, S P , Arani, Arvin

Magnetic Resonance in Medicine | January 17, 2016 | Volume: 77 | Issue: 1 | Pages: 351-360

10.1002/mrm.26101 | PMID 26778442 Get It

Purpose Noninvasive stiffness imaging techniques (elastography) can image myocardial tissue biomechanics in vivo. For cardiac MR elastography (MRE) techniques, the optimal vibration frequency for in vivo experiments is unknown. Furthermore, the accuracy of cardiac MRE has never been evaluated in a geometrically accurate phantom. Therefore, the purpose of this study was to determine the necessary driving frequency to obtain accurate three‐dimensional (3D) cardiac MRE stiffness estimates in a geometrically accurate diastolic cardiac phantom and to determine the optimal vibration frequency that can be introduced in healthy volunteers. Methods The 3D cardiac MRE was performed on eight healthy volunteers using 80 Hz, 100 Hz, 140 Hz, 180 Hz, and 220 Hz vibration frequencies. These frequencies were tested in a geometrically accurate diastolic heart phantom and compared with dynamic mechanical analysis (DMA). Results The 3D Cardiac MRE was shown to be feasible in volunteers at frequencies as high as 180 Hz. MRE and DMA agreed within 5% at frequencies greater than 180 Hz in the cardiac phantom. However, octahedral shear strain signal to noise ratios and myocardial coverage was shown to be highest at a frequency of 140 Hz across all subjects. Conclusion This study motivates future evaluation of high‐frequency 3D MRE in patient populations. Magn Reson Med 77:351–360, 2017. © 2016 Wiley Periodicals, Inc.
MMSET is dynamically regulated during cell-cycle progression and promotes normal DNA replication
Evans, Debra L., Zhang, Haoxing , Ham, Hyoungjun , Pei, Huadong , Lee, SeungBaek, Kim, Jung-Jin, Billadeau, Daniel D. , Lee, Seung Baek , Kim, JungJin, Lee, SeungBaek , Lou, Zhenkun , Lee, Seung Baek

Cell Cycle | January 16, 2016 | Volume: 15 | Issue: 1 | Pages: 95-105

10.1080/15384101.2015.1121323 | PMID 26771714 Get It

Care of Women During Menopause
Kransdorf, Lisa N. , Files, Julia A. , Mayer, Anita P. , Kransdorf, Lisa N

Journal of Women's Health | January 16, 2016 | Volume: 25 | Issue: 1 | Pages: 11-14

10.1089/jwh.2015.5646 | PMID 26771560 Get It

We would like to introduce a new section in the Journal of Women's Health , the Clinical Update. Important studies are continually published in both this Journal and other medical publications. However, it is difficult for busy providers to stay current with the changing literature. The Clinical Update is designed to serve as a review of recently published, high-impact, and potentially practice-changing journal articles, digested for our readers. The Clinical Update will be published on a quarterly basis. Each edition of the update will focus on a specific women's health topic, with planned topics to include menopause, sexual dysfunction, breast health, contraception, osteoporosis, and cardiovascular disease.
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth
Hu, Brian , Fairey, Adrian, Madhav, Anisha, Yang, Dongyun , Li, Meng , Groshen, Susan , Stephens, Craig, Kim, Philip H., Virk, Navneet, Martin, Sue Ellen , Erho, Nicholas , Jenkins, Robert B., Den, Robert B. , Xu, Tong , Xu, Yucheng, Gill, Inderbir S. , Goldkorn, Amir , Wang, Lina , Davicioni, Elai , Quinn, David I , Den, Robert B , Gill, Inderbir S

The Prostate | January 16, 2016 | Volume: 76 | Issue: 6 | Pages: 597-608

10.1002/pros.23151 | PMID 26771938 Get It

Is normal pressure hydrocephalus becoming less idiopathic?
Graff‐Radford, Neill R.

Neurology | January 16, 2016 | Volume: 86 | Issue: 7 | Pages: 588-589

10.1212/wnl.0000000000002377 | PMID 26773075 Get It

Challenging the Dogma of Tourniquet Pressure Requirements for Upper Extremity Surgery
Sarfani, Shumaila , Cantwell, Sean , Shin, Alexander Y. , Kakar, Sanjeev

Journal of Wrist Surgery | January 15, 2016 | Volume: 05 | Issue: 02 | Pages: 120-123

10.1055/s-0036-1571281 | PMID 27104077 Get It

Faculty Opinions recommendation of Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.
Fernández-Zapico, Martín E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 15, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725773126.793511210 Get It